Home Criteria of adequacy for vitamin D testing and prevalence of deficiency in clinical practice
Article
Licensed
Unlicensed Requires Authentication

Criteria of adequacy for vitamin D testing and prevalence of deficiency in clinical practice

  • Fernando Granado-Lorencio EMAIL logo , Inmaculada Blanco-Navarro and Belén Pérez-Sacristán
Published/Copyright: October 14, 2015

Abstract

Background:

Vitamin D deficiency is an important concern in clinical settings although there is no consensus on who should undergo 25-OH-vitamin D testing. We studied the prevalence of vitamin D deficiency before and after introducing adequacy (clinical and biochemical) criteria for testing.

Methods:

A total of 32,363 tests for 25-OH-vitamin D were retrospectively evaluated. Requests were unrestricted until December 2010 and justification criteria were applied from January 2011. During 6 years, 25,656 samples were analyzed (UHPLC) of which 12,315 were considered the first visit. The prevalence of deficiency was assessed for all the samples and according to the year, sex, season, age, origin of the requests, inclusion of adequacy criteria and consecutive visits.

Results:

A significant proportion of the requests (25%) were unjustified and less than half of the clinically or biochemically-justified tests displayed serum concentrations indicative of deficiency. Application of adequacy criteria resulted in a non-significant increase in the prevalence of deficiency, both at the first visit (36.5 vs. 41.7, p=0.17) and for all the samples analyzed (32.0 vs. 35.5, p=0.14). The percentage of deficiency decreased in consecutive visits although 2/3 and 41% of the patients remained deficient on the second and third visit, respectively. Moreover, at least 1/5 of sufficient patients at the first test became deficient in subsequent evaluations.

Conclusions:

A significant proportion of the requests was unjustified by clinical or biochemical criteria. Our data also indicate that clinical and biochemical criteria may be necessary (to be present) to justify vitamin D testing but not sufficient (predictive) to indicate the presence of vitamin D deficiency.


Corresponding author: Fernando Granado-Lorencio, Unidad de Vitaminas, Servicio de Bioquímica Clínica, Hospital Universitario Puerta de Hierro-Majadahonda, 28222-Madrid, Spain, Phone: +34-911917578/7756, E-mail: ; ; and Grupo Metabolismo y Nutrición, IDIPHIM, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain

Acknowledgments

The present work was performed as part of the laboratory assistance offered to the covered population. No additional funding sources were used.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Kennel KA, Drake MT, Hurley DL. Vitamin D Deficiency in Adults: When to Test and How to Treat. Mayo Clin Proc 2010;85:752–8.10.4065/mcp.2010.0138Search in Google Scholar

2. Health Quality Ontario. Clinical utility of vitamin D testing: an evidence-based analysis. Ont Health Technol Assess Ser 2010:10:1–95.Search in Google Scholar

3. IOM. Institute of Medicine Food and Nutrition Board. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academy Press, 2011.Search in Google Scholar

4. Scragg R. Vitamin D and public health: an overview of recent research on common diseases and mortality in adulthood. Publ Health Nutr 2011:14:1515–32.10.1017/S1368980011001455Search in Google Scholar

5. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton S, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab 2011:96:53–8.10.1210/jc.2010-2704Search in Google Scholar

6. Glendenning P, Inderjeeth CA. Vitamin D; methods of 25 hydroxyvitamin D analysis, targeting at risk populations and selecting thresholds of treatment. Clin Biochem 2012:45:901–6.10.1016/j.clinbiochem.2012.04.002Search in Google Scholar

7. Aspray TJ, Bowring C, Fraser W, Gittoes N, Javaid MK, MacDonald H, et al. National osteoporosis society vitamin D guideline summary. Age Ageing 2014:43:592–5.10.1093/ageing/afu093Search in Google Scholar

8. Scott MG, Gronowski AM, Reid I, Holick MF, Thadhani R, Phinney K. Vitamin D: the more we know, the less we know. Clin Chem 2015:61:462–5.10.1373/clinchem.2014.222521Search in Google Scholar

9. Sattar N, Welsh P, Panarelli M, Forouhi NG. Increasing requests for vitamin D measurement; costly, confusing and without credibility. Lancet 2012:379:95–6.10.1016/S0140-6736(11)61816-3Search in Google Scholar

10. Bilinski K, Boyages S. Evidence of overtesting for vitamin D in Australia; an analysis of 4.5 years of medicare benefits schedule (MBS) data. Br Med J Open 2013;3:e002955.10.1136/bmjopen-2013-002955Search in Google Scholar PubMed PubMed Central

11. Granado Lorencio F, Blanco-Navarro I, Pérez-Sacristán B. Critical evaluation of assays for vitamin D status. Curr Opini Clin Nutr Metab Care 2013;16:734–40.10.1097/MCO.0b013e328364ca96Search in Google Scholar PubMed

12. Carter G, Phinneym KW. Assessing vitamin D status: time for a rethink? Clin Chem 2014;60:809–11.10.1373/clinchem.2013.219386Search in Google Scholar PubMed

13. Granado-Lorencio F, Simal-Antón A, Herrero-Barbudo C, Blanco-Navarro I, Pérez-Sacristán B. 25-OH-vitamin D in clinical practice: treatment of deficiency or health promotion? Clin Nutr ESPEN 2009;4:e203–5.10.1016/j.eclnm.2009.05.014Search in Google Scholar

14. Holick MF, Binkley NC, Bischoff Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30.10.1210/jc.2011-0385Search in Google Scholar PubMed

15. LeFevre ML; on behalf of the U.S. Preventive Services Task Force. Screening for vitamin D deficiency in adults: U.S preventive services Task Force recommendation statement. Ann Intern Med 2015;162:133–40.10.7326/M14-2450Search in Google Scholar PubMed

16. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. Br Med J 2012;344:e3502.10.1136/bmj.e3502Search in Google Scholar PubMed

17. Schnatz PF, Nudy M, Jiang X, Demko JE, Appt SE. Vitamin D deficiency and cardiovascular disease in postmenopausal women; contributions from the human and nonhuman primate studies. Menopause 2015;22:554–63.10.1097/GME.0000000000000399Search in Google Scholar PubMed

18. Aloia JF. The 2011 report on dietary reference intake for vitamin D: where do we go from here? J Clin Endocrinol Metab 2011;96:2987–96.10.1210/jc.2011-0090Search in Google Scholar PubMed

19. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 2012;9:709–15.10.1016/j.autrev.2010.06.009Search in Google Scholar PubMed

20. Cianferotti L, Marcocci C. Subclinical vitamin D deficiency. Best Pract Res Clin Endocrinol Metab 2012;26:523–37.10.1016/j.beem.2011.12.007Search in Google Scholar PubMed

21. Granado-Lorencio F, Herrero-Barbudo C, Blanco-Navarro I, Pérez-Sacristán B. Suitability of ultra-high performance liquid chromatography for the determination of fat-soluble nutritional status (vitamins A, E, D, and individual carotenoids). Anal Bioanal Chem 2010;397:1389–93.10.1007/s00216-010-3655-2Search in Google Scholar PubMed

22. Tahsin-Swafiri S, Blanco-Navarro I, Pérez-Sacristán B, Millán I, Granado-Lorencio F. The prevalence of vitamin D deficiency in clinical practice is assay-dependent. Clin Nutr 2012;31:1011–4.10.1016/j.clnu.2012.04.009Search in Google Scholar PubMed

23. Grey A, Bolland M, Davidson J. Vitamin D testing. Lancet 2012;379:1699.10.1016/S0140-6736(12)60709-0Search in Google Scholar

24. Fabian E, Bogner M, Kickinger A, Wagner K-H, Elmadfa I. Vitamin status in elderly people in relation to the use of nutritional supplements. J Nutr Health Aging 2012;16:206–12.10.1007/s12603-011-0159-5Search in Google Scholar PubMed

25. Granado-Lorencio F, Blanco-Navarro I, Pérez-Sacristán B, Millán I, Donoso-Navarro E, Silvestre-Mardomingo RA. Determinants of fat-soluble vitamin status in patients aged 65 years and over. Eur J Clin Nutr 2013;67:1325–7.10.1038/ejcn.2013.198Search in Google Scholar PubMed

26. Reid D, Toole BJ, Knox S, Talwar D, Harten J, O’Reilly DS, et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 2011;93:1006–11.10.3945/ajcn.110.008490Search in Google Scholar PubMed

27. Wei M, Yu R, Deutsch SC. Insignificant medium-term vitamin D status change after 25-hydroxyvitamin D testing in a large managed Care population. PLOS One 2014;9:e105571.10.1371/journal.pone.0105571Search in Google Scholar PubMed PubMed Central

28. Lofthus DM, Gadgil JY, de Lemos JA. Overriding concerns: the role of electronic medical record – based best practice alerts in reducing unnecessary laboratory testing. Clin Chem 2015;61:456–8.10.1373/clinchem.2014.236406Search in Google Scholar PubMed

29. Rosen CJ, Taylor C. Common misconceptions about vitamin D – implications for clinicians. Nat Rev Endocrinol 2013;9:434–8.10.1038/nrendo.2013.75Search in Google Scholar PubMed

Received: 2015-8-12
Accepted: 2015-9-14
Published Online: 2015-10-14
Published in Print: 2016-5-1

©2016 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Protein S100B: from cancer diagnostics to the evaluation of mild traumatic brain injury
  4. Reviews
  5. Capillary electrophoresis based on nucleic acid detection for diagnosing human infectious disease
  6. Oxidative damage and the pathogenesis of menopause related disturbances and diseases
  7. Opinion Paper
  8. EFLM WG-Preanalytical phase opinion paper: local validation of blood collection tubes in clinical laboratories
  9. Genetics and Molecular Diagnostics
  10. Effective quality management practices in routine clinical next-generation sequencing
  11. Analysis of PMP22 duplication and deletion using a panel of six dinucleotide tandem repeats
  12. A novel exonuclease (TaqMan) assay for rapid haptoglobin genotyping
  13. General Clinical Chemistry and Laboratory Medicine
  14. Heparinate but not serum tubes are susceptible to hemolysis by pneumatic tube transportation
  15. Criteria of adequacy for vitamin D testing and prevalence of deficiency in clinical practice
  16. A simple clot based assay for detection of procoagulant cell-derived microparticles
  17. Measurement of factor XIII (FXIII) activity by an automatic ammonia release assay using iodoacetamide blank-procedure: no more overestimation in the low activity range and better detection of severe FXIII deficiencies
  18. Immunoassay or LC-MS/MS for the measurement of salivary cortisol in children?
  19. Head to head evaluation of the analytical performance of two commercial methotrexate immunoassays and comparison with liquid chromatography-mass spectrometry and the former fluorescence polarization immunoassay
  20. Reference Values and Biological Variations
  21. Preanalytical, analytical, gestational and pediatric aspects of the S100B immuno-assays
  22. Establishment of reference intervals of clinical chemistry analytes for the adult population in Saudi Arabia: a study conducted as a part of the IFCC global study on reference values
  23. First data on the biological variation and quality specifications for plasma ammonia concentrations in healthy subjects
  24. Cancer Diagnostics
  25. Hypermethylation of DLX4 predicts poor clinical outcome in patients with myelodysplastic syndrome
  26. Cardiovascular Diseases
  27. Galectin-3, osteopontin and successful aging
  28. Platelet volume is associated with the Framingham risk score for cardiovascular disease in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
  29. Infectious Diseases
  30. Diagnostic values of CD64, C-reactive protein and procalcitonin in ventilator-associated pneumonia in adult trauma patients: a pilot study
  31. Corrigendum
  32. Corrigendum to: Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays: a cross-sectional study in Sweden
  33. Letters to the Editor
  34. Theranos phenomenon – part 3
  35. Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice
  36. Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice
  37. Impact of specimen mixing methods on presepsin point-of-care test results using whole blood
  38. Clinical laboratories have a critical role in test strip lot management in glucose point-of-care testing
  39. Hemoglobin A2-Leuven (α2δ2 143(H21) His>Asp): a novel delta-chain variant potentially interfering in hemoglobin A1c measurement using cation exchange HPLC
  40. Eryptosis is induced by hyperthermia in hereditary spherocytosis red blood cells
  41. Investigation of sensitivity for coagulation factor deficiency in APTT and PT: how to perform it?
  42. Underestimation of hepcidin concentration by time of flight mass spectrometry and competitive ELISA in hepcidin p.Gly71Asp heterozygotes
  43. Congress Abstracts
  44. ISMD2016 Eleventh International Symposium on Molecular Diagnostics
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2015-0781/pdf
Scroll to top button